{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:28:38Z","timestamp":1769156918065,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.eurox.2024.100346","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T02:56:00Z","timestamp":1728615360000},"page":"100346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The Association and diagnostic value between Maternal Serum Placental Markers and Placenta Previa"],"prefix":"10.1016","volume":"24","author":[{"given":"Panpan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eurox.2024.100346_bib1","first-page":"388","article-title":"The correlation between placental implantation site and postpartum hemorrhage in patients with dangerous placenta previa and its risk factors analysis","volume":"18","author":"Suxia","year":"2019","journal-title":"J Difficult Dis"},{"key":"10.1016\/j.eurox.2024.100346_bib2","article-title":"Nanotechnological approaches for the treatment of placental dysfunction: Recent trends and future perspectives","volume":"0194","author":"Zhao","year":"2023","journal-title":"Nanomed (Lond)"},{"issue":"5","key":"10.1016\/j.eurox.2024.100346_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/uog.20244","article-title":"Impact of placenta previa with placenta accreta spectrum disorder on fetal growth","volume":"54","author":"Jauniaux","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"06","key":"10.1016\/j.eurox.2024.100346_bib4","first-page":"15","article-title":"Liu. Progress in the diagnosis and treatment of dangerous placenta previa","volume":"45","author":"Yafen","year":"2017","journal-title":"Chin J Clin Dr"},{"key":"10.1016\/j.eurox.2024.100346_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2147\/IJWH.S422187","article-title":"Perinatal outcomes of pregnancy in women with scarred uteri","volume":"15","author":"Wang","year":"2023","journal-title":"Int J Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib6","first-page":"66","article-title":"Progress in the study of the pathogenesis of placenta implantation","volume":"22","author":"Qianyun","year":"2019","journal-title":"Chin J Perinat Med"},{"issue":"37","key":"10.1016\/j.eurox.2024.100346_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034770","article-title":"Current state of interventional procedures to treat pernicious placenta previa accompanied by placenta accreta spectrum: A review","volume":"102","author":"Zhao","year":"2023","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12884-018-1935-6","article-title":"Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study","volume":"18","author":"Cui","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.eurox.2024.100346_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2147\/IJWH.S379965","article-title":"Analysis of the risk factors for massive hemorrhage in pernicious placenta previa and evaluation of the efficacy of internal iliac artery balloon occlusion","volume":"14","author":"Zhang","year":"2022","journal-title":"Int J Women\u2019s Health"},{"issue":"14","key":"10.1016\/j.eurox.2024.100346_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015025","article-title":"Successful resuscitation of a patient with pernicious placenta previa and placenta accreta who had massive life-threatening bleeding during cesarean section: a case report","volume":"98","author":"Jiang","year":"2019","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0300060518801455","article-title":"Prophylactic uterine artery embolization in second-trimester pregnancy termination with complete placenta previa","volume":"47","author":"Wang","year":"2019","journal-title":"J Int Med Res"},{"issue":"4","key":"10.1016\/j.eurox.2024.100346_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10396-019-00965-z","article-title":"Value of ultrasound scoring system for assessing risk of pernicious placenta previa with accreta spectrum disorders and poor pregnancy outcomes","volume":"46","author":"Zhu","year":"2019","journal-title":"J Med Ultrason (2001)"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12905-022-02107-z","article-title":"Value of 3d ultrasound flow imaging combined with serum afp, \u03b2-hCG, sflt-1 and ck in the diagnosis of placenta accreta","volume":"22","author":"Cai","year":"2022","journal-title":"BMC Women\u2019s Health"},{"issue":"6","key":"10.1016\/j.eurox.2024.100346_bib14","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.21037\/apm-21-1285","article-title":"Clinical diagnostic value and analysis of mri combined with ultrasound in prenatal pernicious placenta previa with placenta accreta","volume":"10","author":"Guo","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.eurox.2024.100346_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2023.1068377","article-title":"Absence of abnormal vascular changes on prenatal imaging aids in differentiating simple uterine scar dehiscence from placenta accreta spectrum: a case series","volume":"5","author":"Adu-Bredu","year":"2023","journal-title":"Front Reprod Health"},{"key":"10.1016\/j.eurox.2024.100346_bib16","article-title":"Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases","author":"Aryananda","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"07","key":"10.1016\/j.eurox.2024.100346_bib17","first-page":"851","article-title":"Diagnostic efficacy of ultrasound scoring method combined with human chorionic gonadotropin beta, alpha-fetoprotein, and creatine kinase in the diagnosis of dangerous placenta previa with placenta implantation","volume":"44","author":"Li","year":"2023","journal-title":"J Hebei Med Univ"},{"issue":"22","key":"10.1016\/j.eurox.2024.100346_bib18","first-page":"4307","article-title":"The value of serum analytes combined with ultrasound in predicting placental implantation in early pregnancy screening for aneuploidy","volume":"37","author":"Jieli","year":"2022","journal-title":"Chin J Matern Child Health Care"},{"key":"10.1016\/j.eurox.2024.100346_bib19","first-page":"481","article-title":"Obstetrics Group of Obstetrics and Gynecology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of placenta implantation (2015)","volume":"7","author":"Perinatal Medicine Branch of Chinese Medical Association","year":"2015","journal-title":"Chin J Perinat Med"},{"key":"10.1016\/j.eurox.2024.100346_bib20","series-title":"Ultrasound scanning at 11 to 13+6 weeks of gestation [M]. Liang DY, Liu ZJ, Translation.","first-page":"17","author":"Nicolaidis","year":"2004"},{"issue":"3","key":"10.1016\/j.eurox.2024.100346_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13167-020-00212-3","article-title":"A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy","volume":"11","author":"Chen","year":"2020","journal-title":"Epma J"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12884-023-06103-5","article-title":"Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: A retrospective single-centre cross-sectional study","volume":"23","author":"Ghaem Maghami","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.eurox.2024.100346_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2023.11.003","article-title":"Association between human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes: A systematic review and meta-analysis","volume":"34","author":"Skogler","year":"2023","journal-title":"Pregnancy Hypertens"},{"issue":"11","key":"10.1016\/j.eurox.2024.100346_bib24","first-page":"1903","article-title":"Study on the correlation between serum hcg, afp expression and placenta previa implantation classification","volume":"57","author":"Lijuan","year":"2022","journal-title":"Jiangxi Med J"},{"key":"10.1016\/j.eurox.2024.100346_bib25","article-title":"Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study","author":"Sovio","year":"2023","journal-title":"Bjog"},{"issue":"7","key":"10.1016\/j.eurox.2024.100346_bib26","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.12669\/pjms.38.7.5248","article-title":"Prediction performance of serum placental growth factor (plgf) human chorionic gonadotropin \u03b2 (\u03b2-hCG) and papp-a levels in early pregnancy for pregnancy outcomes","volume":"38","author":"Guo","year":"2022","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.eurox.2024.100346_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/jrms.JRMS_560_20","article-title":"Role of pregnancy-associated plasma protein a (papp-a) and human-derived chorionic gonadotrophic hormone (free \u03b2-hCG) serum levels as a marker in predicting of small for gestational age (sga): a cohort study","volume":"26","author":"Honarjoo","year":"2021","journal-title":"J Res Med Sci"},{"issue":"09","key":"10.1016\/j.eurox.2024.100346_bib28","first-page":"191","article-title":"Research progress on the relationship between prenatal serological indicators and adverse pregnancy outcomes in early pregnancy","volume":"26","author":"Min","year":"2020","journal-title":"Contemp Med"},{"issue":"9","key":"10.1016\/j.eurox.2024.100346_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/gtmb.2022.0083","article-title":"Recurrence rate for isolated elevated maternal serum alpha-fetoprotein levels and pregnancy outcomes","volume":"26","author":"Ayyash","year":"2022","journal-title":"Genet Test Mol Biomark"},{"issue":"6","key":"10.1016\/j.eurox.2024.100346_bib30","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/01443615.2022.2055452","article-title":"The predictive value of maternal serum afp to papp-a or b-hcg ratios in spontaneous preterm birth","volume":"42","author":"Celik","year":"2022","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.eurox.2024.100346_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000492829","article-title":"Second trimester biochemical markers as possible predictors of pathological placentation: A retrospective case-control study","volume":"46","author":"Berezowsky","year":"2019","journal-title":"Fetal Diagn Ther"},{"issue":"10","key":"10.1016\/j.eurox.2024.100346_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/15353702221080458","article-title":"Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects","volume":"247","author":"Chen","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.eurox.2024.100346_bib33","article-title":"Advances in human reproductive biomarkers","author":"Mobed","year":"2023","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/10641963.2023.2175848","article-title":"Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study","volume":"45","author":"Dai","year":"2023","journal-title":"Clin Exp Hypertens"},{"issue":"6","key":"10.1016\/j.eurox.2024.100346_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.18821\/0869-2084-2020-65-6-353-357","article-title":"[prognostic significance of specific proteins of pregnancy in women with a uterine scar and placenta accreta.]","volume":"65","author":"Borovkov","year":"2020","journal-title":"Klin Lab Diagn"},{"issue":"23","key":"10.1016\/j.eurox.2024.100346_bib36","doi-asserted-by":"crossref","first-page":"13837","DOI":"10.1111\/jcmm.15973","article-title":"Integrative analysis provides multi-omics evidence for the pathogenesis of placenta percreta","volume":"24","author":"Jiang","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14767058.2016.1275546","article-title":"Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta","volume":"31","author":"B\u00fcke","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.eurox.2024.100346_bib38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/jcm9041108","article-title":"Low first trimester pregnancy-associated plasma protein-a levels are not associated with an increased risk of intrapartum fetal compromise or adverse neonatal outcomes: A retrospective cohort study","volume":"9","author":"Turner","year":"2020","journal-title":"J Clin Med"},{"issue":"18","key":"10.1016\/j.eurox.2024.100346_bib39","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1080\/14767058.2017.1419797","article-title":"Correction to: Farzad mohajeri et. Al., ultrasound measurement of fetal adrenal gland in fetuses with intrauterine growth restriction, an early predictive method for adverse outcomes","volume":"32","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.eurox.2024.100346_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/jpm-2019-0261","article-title":"Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders","volume":"48","author":"Penzhoyan","year":"2019","journal-title":"J Perinat Med"},{"issue":"20","key":"10.1016\/j.eurox.2024.100346_bib41","first-page":"9955","article-title":"Elevated first-trimester papp-a is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes","volume":"27","author":"Balka\u015f","year":"2023","journal-title":"Eur Rev Med Pharm Sci"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161324000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161324000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T02:33:38Z","timestamp":1734057218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590161324000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S2590161324000668"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2024.100346","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association and diagnostic value between Maternal Serum Placental Markers and Placenta Previa","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2024.100346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100346"}}